🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I/II, open-label, multicenter study to assess the efficacy ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04-01
Trial ID
NCT05309213
Treatments Being Tested
Assessment of the Safety and Feasibility of Administering T Cells Expressin...
Status
Unknown
Location
Beijing hospital
Start Date
2016-08-30
Trial ID
NCT03142646
Treatments Being Tested
This is a open-label to assess the efficacy and safety of IM19 CAR-T cells ...
Status
Unknown
Location
First Hospital of China Medical University
Start Date
2022-07-11
Trial ID
NCT05480501
Treatments Being Tested
IM19 CAR-T cell therapy for IgA nephropathy patients with urinary protein a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-13
Trial ID
NCT06690359
Treatments Being Tested
The study is a single-arm, open-label clinical trial intended to recruit 6 ...
Status
Recruiting
Location
Peking Universitiy Third Hospital
Start Date
2024-07-30
Trial ID
NCT06513429
Treatments Being Tested
This is a phase I/II, multicenter study to assess the efficacy and safety o...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2020-06-04
Trial ID
NCT04440436
Treatments Being Tested
Assessment of the Safety and Feasibility of Administering T cells Expressin...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2017-08-21
Trial ID
NCT03344705
Treatments Being Tested
n this study, approximately 30 patients with relapsed or refractory non-Hod...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-05-22
Trial ID
NCT03528421
Treatments Being Tested
This is a phase I/II, open-label, multicenter study to assess the efficacy ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-12-31
Trial ID
NCT05155215
Treatments Being Tested
Assessment of the Safety and Feasibility of Administering T Cells Expressin...
Status
Completed
Location
Hebei Yanda Ludaopei Hospital
Start Date
2017-05-23
Trial ID
NCT03173417
Treatments Being Tested